Results 41 to 50 of about 412,569 (303)

Differences in treatment for substance use disorders by insurance status: Self-help only versus outpatient medical treatment [PDF]

open access: yes, 2020
Background: The role of insurance on substance use disorders (SUD) treatment utilization generally is poorly understood and still less is known on how insurance status relates to the use of evidence-based treatment (i.e., medicalization approach ...
Barnes PhD, Andrew J.   +3 more
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation [PDF]

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2009
"nIntroduction: Drug Utilization Evaluation (DUE) studies are designed to assess drug usage appropriateness. DUEs have traditionally focused on drugs with high price tags, complicated dosage schedules, narrow therapeutic indices and regular side ...
Elnaz Sakhaiyan   +8 more
doaj   +2 more sources

Annotated Bibliography: Understanding Ambulatory Care Practices in the Context of Patient Safety and Quality Improvement. [PDF]

open access: yes, 2016
The ambulatory care setting is an increasingly important component of the patient safety conversation. Inpatient safety is the primary focus of the vast majority of safety research and interventions, but the ambulatory setting is actually where most ...
Mehdi, Harshal   +2 more
core   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

NO‐Driven Janus Nanomotor Enhances T‐Cell Infiltration by Reconstructing Tumor‐Associated Blood and Lymphatic Vessels

open access: yesAdvanced Science
The effectiveness of antitumor immunotherapy is limited to immune cell infiltration into solid tumors, primarily via T‐cell migration through tumor blood vessels.
Qingping Ma   +15 more
doaj   +1 more source

Single-cell RNA sequencing in atherosclerosis: Mechanism and precision medicine

open access: yesFrontiers in Pharmacology, 2022
Atherosclerosis is the pathological basis of various vascular diseases, including those with high mortality, such as myocardial infarction and stroke. However, its pathogenesis is complex and has not been fully elucidated yet.
Qiaoyu Li   +27 more
doaj   +1 more source

Controlling Costs and Increasing Access to Prescription Drugs: State and Federal Solutions [PDF]

open access: yes, 2002
Spending on health care in the United States continues to increase rapidly, consuming a greater share of the total economy each year. Over the past decade, prescription drug spending has been the fastest growing component of health care expenditures both
Michael Sullivan, Rebecca Kavoussi
core  

Drug Utilization Evaluation of Prantaprazole

open access: yesInternational Journal of Advanced Research in Science, Communication and Technology
Drug Utilization Review (DUR) is an ongoing and planned process of quality improvement to ensure the safe, effective, and appropriate use of drugs. It implies comprehensive review of a patient's drug and medical history prior to, during, and subsequent to dispensing the medication for optimal therapeutic results.
null Shubhangi Netaji Shindalkar   +4 more
openaire   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy